GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently gaining a significant focus in therapeutic studies, largely due to its remarkable impact on managing conditions such as adult-onset diabetes and obesity. Ongoing trials have revealed that more than glucose management, GLP-1 medications offer potential for heart function and po